The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.
about
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@en
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@nl
type
label
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@en
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@nl
prefLabel
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@en
The IL-17B-IL-17 receptor B pa ...... ivation of the ERK1/2 pathway.
@nl
P2093
P2860
P50
P356
P1433
P1476
The IL-17B-IL-17 receptor B pa ...... tivation of the ERK1/2 pathway
@en
P2093
Andrew J Sanders
Cécile Dejou
Emilie Laprevotte
Gilles Alberici
Henri-Alexandre Michaud
Jean-François Eliaou
Jérémy Bastid
Kathryn A Frewer
Marion Philippe
Nathalie Bonnefoy
P2860
P304
113360-113372
P356
10.18632/ONCOTARGET.23008
P407
P577
2017-12-06T00:00:00Z